|
| Own Slots | ||
|---|---|---|
| Slot Name | Value | |
 |
Alternatives | |
|
CanImprove | |
|
CautionWithMedicationsUsed | |
|
Contraindication | |
|
CouldBeRelatedTo | Acute_heart_failure |
|
Cui | C1176308 |
|
Definition | Tolvaptan (INN), also known as OPC-41061, is a selective, competitive arginine vasopressin receptor 2 antagonist under investigation as a potential treatment for fluid retention and hyponatremia (low blood sodium levels) associated with congestive heart failure. |
|
SideEffect | |
|
Synonyms | |
|
UMLSSynonyms | |
|
UsedTogetherWithMedication | Loop_diuretics_and_metolazone |